Coastline Trust Co grew its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 71.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,746 shares of the conglomerate’s stock after acquiring an additional 5,312 shares during the quarter. Coastline Trust Co’s holdings in Danaher were worth $2,918,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. JPL Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in Danaher in the second quarter valued at approximately $27,000. ANTIPODES PARTNERS Ltd bought a new position in Danaher in the third quarter valued at approximately $27,000. Finally, TruNorth Capital Management LLC acquired a new position in shares of Danaher in the third quarter valued at approximately $28,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Activity
In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on DHR
Danaher Stock Performance
Shares of DHR stock opened at $190.42 on Friday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The company’s fifty day simple moving average is $215.31 and its 200-day simple moving average is $214.96. The firm has a market cap of $134.66 billion, a PE ratio of 37.78, a P/E/G ratio of 2.60 and a beta of 0.93. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. During the same quarter last year, the firm earned $2.14 earnings per share. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a $0.40 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s dividend payout ratio (DPR) is presently 25.40%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
